Home > Drugs A – Z > Cromolyn

Cromolyn

What works?

Learn more about the effects of these drugs. The most reliable research is summed up for you in our featured article.

By breathing

Cromolyn is used to prevent the symptoms of asthma. When it is used regularly, cromolyn lessens the number and severity of asthma attacks by reducing… Read more

Brand names include: Intal, Intal Inhaler

By mouth

Cromolyn is used to treat the symptoms of mastocytosis. Mastocytosis is a rare condition caused by too many mast cells in the body. These mast cells release… Read more

Brand names include: Gastrocrom

Into the eye

Cromolyn ophthalmic solution is used in the eye to treat certain disorders of the eye caused by allergies. It works by acting on certain cells, called… Read more

Brand names include: Crolom

Into the nose

Cromolyn nasal solution is used to help prevent or treat the symptoms (sneezing, wheezing, runny nose, itching) of seasonal (short-term) or chronic (long-term)… Read more

Brand names include: Nasalcrom

Drug classes About this
Antiasthma, Gastrointestinal Agent, Nasal Agent, Ophthalmologic Agent

What works? Research summarized

Evidence reviews

Cromolyn sodium for the prevention of chronic lung disease in preterm infants

Review question: What is the effect of prophylactic administration of cromolyn sodium on the incidence of chronic lung disease at 28 days or 36 weeks' postmenstrual age (PMA), mortality, or the combined outcome of mortality or chronic lung disease at 28 days or 36 weeks' PMA in preterm infants.

Nedocromil sodium versus sodium cromoglycate for preventing exercise‐induced bronchoconstriction

Exercise‐induced asthma can limit people's endurance, prolong recovery time after exercise, and lead to people avoiding exercise. The episode involves symptoms such as coughing, wheezing, shortness of breath and chest tightness. Two drugs, nedocromil sodium (Tilade) and sodium cromoglycate are sometimes used before exercise to prevent asthma. The review of trials found that both were similarly effective in relieving exercise‐induced asthma for both children and adults. More people have sore throats and an unpleasant after‐taste after using nedocromil sodium.

The effects of sodium cromoglycate compared with placebo for chronic asthma in children

In this review we aimed to determine whether there is evidence for the effectiveness of inhaled sodium cromoglycate as maintenance treatment in children with chronic asthma. Most of the studies were carried out in small groups of patients. Furthermore, we suspect that not all studies undertaken have been published. The results show that there is insufficient evidence to be sure about the beneficial effect of sodium cromoglycate compared to placebo. However, for several outcome measures the results favoured sodium cromoglycate.

See all (21)

Summaries for consumers

Cromolyn sodium for the prevention of chronic lung disease in preterm infants

Review question: What is the effect of prophylactic administration of cromolyn sodium on the incidence of chronic lung disease at 28 days or 36 weeks' postmenstrual age (PMA), mortality, or the combined outcome of mortality or chronic lung disease at 28 days or 36 weeks' PMA in preterm infants.

Nedocromil sodium versus sodium cromoglycate for preventing exercise‐induced bronchoconstriction

Exercise‐induced asthma can limit people's endurance, prolong recovery time after exercise, and lead to people avoiding exercise. The episode involves symptoms such as coughing, wheezing, shortness of breath and chest tightness. Two drugs, nedocromil sodium (Tilade) and sodium cromoglycate are sometimes used before exercise to prevent asthma. The review of trials found that both were similarly effective in relieving exercise‐induced asthma for both children and adults. More people have sore throats and an unpleasant after‐taste after using nedocromil sodium.

The effects of sodium cromoglycate compared with placebo for chronic asthma in children

In this review we aimed to determine whether there is evidence for the effectiveness of inhaled sodium cromoglycate as maintenance treatment in children with chronic asthma. Most of the studies were carried out in small groups of patients. Furthermore, we suspect that not all studies undertaken have been published. The results show that there is insufficient evidence to be sure about the beneficial effect of sodium cromoglycate compared to placebo. However, for several outcome measures the results favoured sodium cromoglycate.

See all (8)

PubMed Health Blog...

read all...